mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.3 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.0084 |
0.8 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.1 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.8 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.004 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.0082 |
0.8 |